(2022) Dose-response relationship between weight loss and improvements in obstructive sleep apnea severity after a diet/lifestyle interventions: secondary analyses of the MIMOSA randomized clinical trial Olukorode, John O., et al (2024) Recent Advances and Therapeutic Benefits of Glucagon-Like Peptide-1 (GLP-1) Agonists in the Management of Type 2 Diabetes and Associated Metabolic Disorders Olukorode, John O., et al (2024) Recent Advances and Therapeutic Benefits of Glucagon-Like Peptide-1 (GLP-1) Agonists in the Management of Type 2 Diabetes and Associated Metabolic Disorders Olukorode, John O., et al (2024) Recent Advances and Therapeutic Benefits of Glucagon-Like Peptide-1 (GLP-1) Agonists in the Management of Type 2 Diabetes and Associated Metabolic Disorders Gonzolaz-Rellan, Maria J., Drucker, Daniel J
Side effects vary by individual, but many patients report better tolerance compared to other injectable medications
7 To address these issues, researchers are investigating naturally occurring peptides
Injecting unregulated peptides carries risks including infection, immune reactions, and adverse effects from unknown contaminants
Annu Rev Nutr 35, 135-173